Home » Stocks » ALTP

Altamont Pharma Acquisition Corp. (ALTP)

Altamont Pharma Acquisition will go public soon, but the exact IPO date is still unknown.
Stock Price: $10.00
Confirmed IPO price
Market Cap 125.00M
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out 12.50M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day n/a
Last Price n/a
Previous Close n/a
Change ($) n/a
Change (%) n/a
Day's Open n/a
Day's Range n/a
Day's Volume n/a
52-Week Range n/a

News

Hide News

Altamont Pharma Acquisition, a blank check company targeting the biopharma and medical technology sectors, filed on Tuesday with the SEC to raise up to $100 million in an initial public offering.

3 weeks ago - NASDAQ

Altamont Pharma Acquisition Corp. has filed to go public with an IPO on the NASDAQ.

3 weeks ago - SEC

About ALTP

Altamont Pharma Acquisition is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It is our intention to pursue prospective targets that are focused on healthcare innovation. We anticipate targeting companies domiciled in North America or Europe that are developing assets in the biopharma and medical technology sectors, which aligns with our management team’s experience in healthcare investing and dru... [Read more...]

Industry
Blank Checks / SPAC
IPO Date
Pending
CEO
Mark Pearson
Country
United States
Stock Exchange
NASDAQ
Ticker Symbol
ALTP
Full Company Profile